Research Topics
| KIMBERLY A contact YONKERSSummaryAffiliation: Yale University Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Special issues related to the treatment of depression in womenKimberly A Yonkers
Department of Psychiatry, Yale University, New Haven, CT 06510, USA
J Clin Psychiatry 64:8-13. 2003..More research is needed, however, that examines how the balance between estrogen, progesterone, and other hormones affects neurotransmitter function...
Symptom-onset treatment for women with premenstrual dysphoric disorderKimberly A Yonkers
Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06510, USA
J Clin Psychopharmacol 26:198-202. 2006..Many women have less than a week of symptoms, and shorter treatment intervals would further reduce medication exposure and costs...
Motivational enhancement therapy coupled with cognitive behavioral therapy versus brief advice: a randomized trial for treatment of hazardous substance use in pregnancy and after deliveryKimberly A Yonkers
Department of Psychiatry, the School of Epidemiology and Public Health, Yale University School of Medicine, New Haven, CT 06510, USA
Gen Hosp Psychiatry 34:439-49. 2012..The objective was to compare the efficacy of motivational enhancement therapy coupled with cognitive behavioral therapy (MET-CBT) to brief advice for treatment of substance use in pregnancy...
Depression and serotonin reuptake inhibitor treatment as risk factors for preterm birthKimberly A Yonkers
Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06510, USA
Epidemiology 23:677-85. 2012..Studies that have attempted to separate effects of illness from treatment have been inconclusive. We sought to explore the separate effects of SRI use and major depressive episodes in pregnancy on risk of preterm birth...
Prenatal hazardous substance use and adverse birth outcomesOdayme Quesada
Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06510, USA
J Matern Fetal Neonatal Med 25:1222-7. 2012..Assess the relative effects of a variety of illicit and licit drugs on risk for adverse birth outcomes...
Pharmacologic treatment of postpartum women with new-onset major depressive disorder: a randomized controlled trial with paroxetineKimberly A Yonkers
Department of Psychiatry, Yale University School of Medicine, New Haven, Conn, USA
J Clin Psychiatry 69:659-65. 2008..The current study determined the relative efficacy of paroxetine compared to placebo in the treatment of acute postpartum MDD...
Premenstrual syndromeKimberly Ann Yonkers
Department of Psychiatry, Yale School of Medicine, CT 06510, USA
Lancet 371:1200-10. 2008..The effectiveness of serotonin reuptake inhibitors, taken throughout the cycle or during luteal phases only, is also well established...
Depression screening of perinatal women: an evaluation of the healthy start depression initiativeKimberly A Yonkers
Department of Psychiatry, Yale School of Medicine, New Haven, CT 06510, USA
Psychiatr Serv 60:322-8. 2009..This study evaluated the Healthy Start depression initiative to assess whether it resulted in diminished rates of depressive symptoms and increased rates of detection, referral, and treatment among pregnant and postpartum women...
A treatment for substance abusing pregnant womenKimberly Ann Yonkers
Perinatal Research Program, Department of Psychiatry, Yale University School of Medicine, 142 Temple Street, New Haven, CT 06510, USA
Arch Womens Ment Health 12:221-7. 2009..Treatment fidelity was assessed using the Yale Adherence and Competence System. Behavioral treatment delivery in this setting is feasible and is being evaluated in a randomized, controlled, clinical trial...
Typical somatic symptoms of pregnancy and their impact on a diagnosis of major depressive disorderKimberly Ann Yonkers
Department of Psychiatry, Yale School of Medicine, New Haven, CT 06510, USA
Gen Hosp Psychiatry 31:327-33. 2009..We sought to determine whether trimester of pregnancy influences the ability to diagnose major depressive disorder (MDD)...
The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and GynecologistsKimberly A Yonkers
Department of Psychiatry, Epidemiology and Public Health, Yale School of Medicine, New Haven, CT 06510, USA
Obstet Gynecol 114:703-13. 2009..To address the maternal and neonatal risks of both depression and antidepressant exposure and develop algorithms for periconceptional and antenatal management...
The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and GynecologistsKimberly A Yonkers
Department of Psychiatry, Epidemiology and Public Health, Yale School of Medicine, New Haven, CT 06510, USA
Gen Hosp Psychiatry 31:403-13. 2009..To address the maternal and neonatal risks of both depression and antidepressant exposure and develop algorithms for periconceptional and antenatal management...
Screening for prenatal substance use: development of the Substance Use Risk Profile-Pregnancy scaleKimberly A Yonkers
Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA
Obstet Gynecol 116:827-33. 2010..To report on the development of a questionnaire to screen for hazardous substance use in pregnant women and to compare the performance of the questionnaire with other drug and alcohol measures...
Diagnosis, pathophysiology, and management of mood disorders in pregnant and postpartum womenKimberly Ann Yonkers
Yale School of Medicine, New Haven, Connecticut, USA
Obstet Gynecol 117:961-77. 2011..Comanagement of their care with psychiatrists will increase their chances of avoiding a recurrence of illness...
Does antidepressant use attenuate the risk of a major depressive episode in pregnancy?Kimberly A Yonkers
Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06510, USA
Epidemiology 22:848-54. 2011..We sought to estimate differences in the risk of developing a new major depressive episode among pregnant and postpartum women with recurrent illness who either did or did not use antidepressants...
Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorderKimberly A Yonkers
Department of Psychiatry, Yale University, New Haven, Connecticut 06510, USA
Obstet Gynecol 106:492-501. 2005..To compare the efficacy of a new low-dose oral contraceptive pill (OCP) formulation with placebo in reducing symptoms of premenstrual dysphoric disorder...
Onset and persistence of postpartum depression in an inner-city maternal health clinic systemK A Yonkers
Department of Psychiatry, University of Texas, Southwestern Medical Center, Dallas, USA
Am J Psychiatry 158:1856-63. 2001....
The pharmacologic treatment of depression: is gender a critical factor?Kimberly A Yonkers
Department of Psychiatry, Yale School of Medicine, New Haven, Conn, USA
J Clin Psychiatry 63:610-5. 2002..In this article, current information regarding potential sex differences in the pharmacotherapy of major depressive disorder is reviewed...
Chronicity, relapse, and illness--course of panic disorder, social phobia, and generalized anxiety disorder: findings in men and women from 8 years of follow-upKimberly A Yonkers
Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut 06510, USA
Depress Anxiety 17:173-9. 2003..It may be that sex differences in the clinical course of anxiety disorders hold prognostic implications for patients with these illnesses...
Paroxetine treatment of mood disorders in women: premenstrual dysphoric disorder and hot flashesKimberly A Yonkers
Yale University School of Medicine, New Haven, CT 06510, USA
Psychopharmacol Bull 37:135-47. 2003..The clinical trials experience with paroxetine and the controlled-release (CR) formulation of paroxetine is reviewed...
Premenstrual disorders: bridging research and clinical realityK A Yonkers
Yale School of Medicine, Department of Psychiatry and School of Public Health, New Haven, CT 06510, USA
Arch Womens Ment Health 6:287-92. 2003..These requirements likely influence critical patient characteristics rendering trial participants and typical patients seeking treatment, very different...
Management of bipolar disorder during pregnancy and the postpartum periodKimberly A Yonkers
Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06510, USA
Am J Psychiatry 161:608-20. 2004..The authors summarize knowledge regarding the management of bipolar disorder during pregnancy and the postpartum period, with a focus on managing mania, hypomania, and the psychotic components of the illness...
An eight-year longitudinal comparison of clinical course and characteristics of social phobia among men and womenK A Yonkers
Department of Psychiatry, Yale University School of Medicine, 142 Temple Street, New Haven, CT 06510, USA
Psychiatr Serv 52:637-43. 2001..Data from an eight-year longitudinal study were analyzed to investigate the course of social phobia and to explore potential sex differences in the course and characteristics of the illness...
Luteal phase treatment of premenstrual dysphoric disorder improves symptoms that continue into the postmenstrual phaseKimberly A Yonkers
J Affect Disord 85:317-21. 2005..Furthermore, no previous study has explored whether abruptly stopping medication after 2 weeks of treatment is associated with discontinuation symptoms...
Symptoms of posttraumatic stress disorder in a community sample of low-income pregnant womenMegan V Smith
Department of Psychiatry, Yale University, 142 Temple St, Suite 301, New Haven, CT 06510, USA
Am J Psychiatry 163:881-4. 2006..5%, N=82), compared to nonpregnant women (79.4%, N=464). CONCLUSIONS: PTSD in pregnancy was associated with comorbidity, poor health behaviors, and lower recall of memory-related PTSD symptoms. Further prospective study is needed...
Success of mental health referral among pregnant and postpartum women with psychiatric distressMegan V Smith
Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, CT 06510, USA
Gen Hosp Psychiatry 31:155-62. 2009..This study measured rates of and determined factors associated with mental health service use among a cohort of 465 pregnant and postpartum women receiving care from publicly funded obstetric clinics...
Randomized, placebo-controlled trial of fluoxetine for acute treatment of minor depressive disorderLewis L Judd
Department of Psychiatry, University of California, San Diego, 9500 Gilman Dr, La Jolla, CA 92093 0603, USA
Am J Psychiatry 161:1864-71. 2004..Minor depressive disorder is both common and associated with significant psychosocial impairment. This study examined antidepressant treatment efficacy in a large group of patients with minor depressive disorder...
Perinatal depression and birth outcomes in a Healthy Start projectMegan V Smith
Departments of Psychiatry and Child Study, Yale University School of Medicine, 142 Temple Street, New Haven, CT 06510, USA
Matern Child Health J 15:401-9. 2011..We cannot exclude the possibility that the community activities of the Healthy Start program promoted increased attention to health issues among depressed women and hence enhance birth outcomes...
Do the PHQ-8 and the PHQ-2 accurately screen for depressive disorders in a sample of pregnant women?Megan V Smith
Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06510, USA
Gen Hosp Psychiatry 32:544-8. 2010..Based upon studies documenting high sensitivity and specificity on the PHQ-8 and PHQ-2 in the general adult population, we hypothesized that both instruments would be effective in this population...
Screening for and detection of depression, panic disorder, and PTSD in public-sector obstetric clinicsMegan V Smith
Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06510, USA
Psychiatr Serv 55:407-14. 2004..Given that depressive disorders among perinatal women are highly prevalent and may have profound impact on infants and children, more work is needed to enhance detection and referral...
Are there differential symptom profiles that improve in response to different pharmacological treatments of premenstrual syndrome/premenstrual dysphoric disorder?Uriel Halbreich
Biobehavior Program, Department of Psychiatry, State University of New York at Buffalo, New York 14214, USA
CNS Drugs 20:523-47. 2006..Such information would also improve understanding of the putative pathophysiological mechanisms underlying PMS and PMDD, and may point to a more specific diagnosis of these conditions...
Management strategies for PMS/PMDDKimberly A Yonkers
Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA
J Fam Pract . 2004
Integration of medical and psychological treatment within the primary health care settingCristine E Hine
Department of Psychiatry, Yale University School of Medicine, 142 Temple St, Suite 301, New Haven, CT 06510, USA
Soc Work Health Care 47:122-34. 2008..It is hypothesized that integration will improve patient access to health care, increase the rate of evidence based practice, improve patient health and satisfaction, and reduce long-term costs...
A descriptive analysis of minor depressionMark Hyman Rapaport
Department of Psychiatry, University of California, San Diego, School of Medicine, La Jolla, 92037, USA
Am J Psychiatry 159:637-43. 2002..The authors provide a detailed clinical description of minor depression: its symptoms, level of disability, stability, and relationship to patient and family history of major depressive disorder...
Research Grants
- ANXIETY, DISINHIBITION, AND RISK FOR DRUG ABUSEKimberly Yonkers; Fiscal Year: 2003..phenotypic indices of vulnerability using combinations of clinical and psychophysiological measures. ..
- Symptom-Onset Antidepressant Treatment for PMDDKimberly A Yonkers; Fiscal Year: 2010..The findings of this study, designed to reflect real-life implementation (i.e., symptom onset), will assist in developing practical treatment guidelines for women with PMDD. ..
- Symptom-Onset Antidepressant Treatment for PMDDKimberly Yonkers; Fiscal Year: 2009..The findings of this study, designed to reflect real-life implementation (i.e., symptom onset), will assist in developing practical treatment guidelines for women with PMDD. ..
- Psychosocial Res. to Improve Drug Treatment in PregnancyKimberly Yonkers; Fiscal Year: 2007..Outcomes for this study are the percentage of days the mother used any substances (primary), reduction in the HIV risk behaviors, (secondary) and assessment of fetal outcomes (secondary). ..
- Effects of Perinatal Depression on PTD and LBWKimberly Yonkers; Fiscal Year: 2007..Further, if we determine antidepressants increase the risk of adverse perinatal outcomes, treatment with psychotherapy rather than antidepressants should be considered when recommending therapeutic options. ..
- Symptom-Onset Antidepressant Treatment for PMDDKimberly Yonkers; Fiscal Year: 2007..The findings of this study, designed to reflect real-life implementation (i.e., symptom onset), will assist in developing practical treatment guidelines for women with PMDD. ..
- Treating PMS/PMDD--Research versus Clinical RealityKimberly Yonkers; Fiscal Year: 2003....
- DETECTION AND TREATMENT OF POSTPARTUM DEPRESSIONKimberly Yonkers; Fiscal Year: 2003..abstract_text> ..
- Project START: Screening to Augment Referral to TreatmentKIMBERLY A contact YONKERS; Fiscal Year: 2010..Costs of the conditions would be estimated to provide models of cost effectiveness. ..
